Exagen Inc (XGN) stock is down -36.60% since Thursday, September 19, 2019 when Exagen Inc began trading. , and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives XGN stock a score of 0 out of a possible 100.
That rank is influenced by a short-term technical score of 0. XGN's rank also includes a long-term technical score of 0. The fundamental score for XGN is 0. In addition to the average rating from Wall Street analysts, XGN stock has a mean target price of 18. This means analysts expect the stock to rise 52.80% over the next 12 months.
What's Happening with XGN Stock Today
Exagen Inc (XGN) stock has fallen -5.38% while the S&P 500 has gained 0.53% as of 3:27 PM on Thursday, May 28. XGN is down -$0.67 from the previous closing price of $12.45 on volume of 21,312 shares. Over the past year the S&P 500 is higher by 1.51% while XGN is down -36.60%. XGN lost -$8.46 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Exagen Inc (XGN) Stock.